美 경쟁약 잇단 허가…셀트리온 7700억 신약, 후발주자 한계 넘을까 김성진 2026.10.28 오전 06:51 Celltrion Adds $70 Million to Share Buybacks as Earnings Rise 나은경 2026.10.26 오후 01:31 Lunit’s Summit deal lifts Korean medical AI stocks[K-Bio Pulse] 나은경 2026.10.27 오전 07:00 셀트리온, 美 카이진과 신약 후보물질 라이선스인 계약…최대 7695억 규모 '빅딜' 김승권 2026.10.22 오전 11:38 Rokit Healthcare Plunges 20% on FDA Warning Letter to U.S. Partner[K-bio Pulse] 김승권 2026.10.23 오전 06:15 Hanmi Signs $2.3B Obesity Drug Deal With Roche[K-Bio Pulse] 김지완 2026.08.25 오전 08:15 Oncocross Soars on Diversification Hopes, ABL Bio Slides on Trial Data[K-Bio Pulse] 송영두 2025.04.03 오전 08:08 Daehwa Pharma stock hits year-high amid China sales optimism[K-Bio Pulse] 유진희 2025.04.15 오전 08:00 CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse] 김진수 2025.03.27 오전 08:29 Aptabio Rallies on Gilead Comparison, Bukwang Drops on $75M Share Sale[K-Bio Pulse] 송영두 2025.03.31 오전 07:40 더 보기 로딩중..
APRIL
APRIL
![Lunit’s Summit deal lifts Korean medical AI stocks[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/10/PS26102700286b.jpg)
![Rokit Healthcare Plunges 20% on FDA Warning Letter to U.S. Partner[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/10/PS26102300285b.jpg)
![Hanmi Signs $2.3B Obesity Drug Deal With Roche[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/08/PS26082500259b.jpg)
![Oncocross Soars on Diversification Hopes, ABL Bio Slides on Trial Data[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/04/PS25040300289b.jpg)
![Daehwa Pharma stock hits year-high amid China sales optimism[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/04/PS25041500244b.jpg)
![CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032700436b.jpg)
![Aptabio Rallies on Gilead Comparison, Bukwang Drops on $75M Share Sale[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25033100100b.jpg)